WO1999032046A1 - Revetement pour fil dentaire en ptfe - Google Patents
Revetement pour fil dentaire en ptfe Download PDFInfo
- Publication number
- WO1999032046A1 WO1999032046A1 PCT/GB1998/003762 GB9803762W WO9932046A1 WO 1999032046 A1 WO1999032046 A1 WO 1999032046A1 GB 9803762 W GB9803762 W GB 9803762W WO 9932046 A1 WO9932046 A1 WO 9932046A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ptfe
- dental floss
- coating
- coating material
- floss
- Prior art date
Links
- 229920001343 polytetrafluoroethylene Polymers 0.000 title claims abstract description 94
- 241000628997 Flos Species 0.000 title claims abstract description 79
- 238000000576 coating method Methods 0.000 title claims abstract description 75
- 239000011248 coating agent Substances 0.000 title claims abstract description 72
- 239000004810 polytetrafluoroethylene Substances 0.000 claims abstract description 93
- 239000000463 material Substances 0.000 claims abstract description 36
- 238000002844 melting Methods 0.000 claims abstract description 30
- 230000008018 melting Effects 0.000 claims abstract description 30
- 239000000654 additive Substances 0.000 claims abstract description 16
- 230000000996 additive effect Effects 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 4
- 239000000194 fatty acid Substances 0.000 claims abstract description 4
- 229930195729 fatty acid Natural products 0.000 claims abstract description 4
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 4
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 27
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 18
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 13
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 13
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 9
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- 235000021314 Palmitic acid Nutrition 0.000 claims description 4
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 150000002943 palmitic acids Chemical class 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 2
- 235000021313 oleic acid Nutrition 0.000 claims description 2
- 150000002889 oleic acids Chemical class 0.000 claims description 2
- 230000007721 medicinal effect Effects 0.000 abstract 1
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 36
- 235000013024 sodium fluoride Nutrition 0.000 description 18
- 239000011775 sodium fluoride Substances 0.000 description 18
- 239000001993 wax Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 9
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 7
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- -1 polytetrafluoroethylene Polymers 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000008368 mint flavor Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical group FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000007852 tooth bleaching agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C15/00—Devices for cleaning between the teeth
- A61C15/04—Dental floss; Floss holders
- A61C15/041—Dental floss
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
Definitions
- the invention relates to a dental floss comprising one or more elongate PTFE elements and a coating applied to increase the coefficient of friction to improve grip properties of the PTFE material.
- the term "dental floss” here includes dental tape .
- dental flosses have been used for many years to clean interdental spaces and spaces under the gum margin.
- a variety of flosses include adjuvants including medicinal compounds e.g. fluoride and bactericidal compounds to increase the effectiveness of the floss in inhibiting dental caries and flavourings to improve taste during flossing. In general these adjuvants are applied in a coating or as a coating on the floss.
- flossing has been shown to be beneficial to oral health, inhibiting dental caries and gum problems, dental floss is considered by many consumers to be uncomfortable to use.
- the problems in consumer acceptance of dental floss relate to its high coefficient of friction. When pulling dental floss between teeth, substantial force may need to be applied. This often results in the floss impacting on the gums, the resulting irritation of the gums often causing bleeding.
- WO96/10478 (US patents 5657779 and 5806539) describes manufacture of a new form of PTFE which is suitable for use as a dental floss, either coated with wax or in uncoated form, by reason of its surface properties.
- EP 335466 and WO92/10978 both also propose that additives, such as dentifrices and components having a pharmaceutical or other beneficial effect when released in the mouth, are incorporated in the dental floss. This might be done either in the wax or as a substrate coating on the PTFE before the wax is applied.
- WO97/24078 discloses a method of incorporating additive in the PTFE material of the floss .
- PTFE has a lower coefficient of friction than conventional materials used to make floss materials, the floss is still effective in cleaning tooth surfaces.
- the reduced friction of coefficient of floss enables the user to insert the floss between tight interdental spaces more easily with reduced propensity for the floss to cause bleeding of the gums .
- the extremely low coefficient of friction of PTFE floss makes the floss difficult to handle.
- wax has been proposed to increase the coefficient of friction of the floss to enable easier grip during use. In use, the wax coating provides an increased coefficient of friction for handling.
- the present invention aims to provide a coating for PTFE floss which results in improved properties and avoids the disadvantage of the sticky feeling of wax on the fingers of the user.
- a dental floss in the form of an elongate article comprising one or more elongate PTFE elements providing the tensile strength of the floss.
- a coating of a coating material which (i) is not a wax
- the present inventors have investigated the possibility of coating of PTFE dental floss using various food quality materials such as mono-, di- and tri- glycerides of stearates and palmitates, and the acids and alcohols of C 14 to C 20 long chain aliphatic compounds. It has surprisingly been found that a class of water- insoluble materials can adhere satisfactorily to the PTFE without impairing the behaviour of the PTFE as a floss and that the coating improves grippability of the product by a user without leaving a sticky residue on the fingers.
- the coating weight can be very small, yet provide a desired coefficient of friction.
- the dental floss of the invention typically has, to provide its tensile strength, one or more strands which are integral, unitary PTFE elements.
- PTFE is here used, as is usual, to describe a range of polymers based on polytetrafluoroethylene .
- small amounts of co-monomers may be included, such as ethylene, chlorotrifluoroethylene or hexafluoropropylene, provided that the properties of the product are satisfactory.
- PTFE is extruded with a lubricant, which is subsequently removed, for example, by heat cleaning or solvent extraction.
- the PTFE may, as is conventional, include one or more fillers and/or pigments.
- unfilled PTFE is preferred.
- PTFE has been expanded by stretching in at least one direction, typically at an elevated temperature, so as to increase in porosity.
- the resulting PTFE has a porous structure.
- Suitable PTFE materials are described in WO96/10478 (US patents 5657779 and 5806539) .
- a porous PTFE material is used, with a density of not more than 1.5g/cm 3 .
- the tensile strength of the PTFE is at least 100 MPa, e.g. in the range 200 - 600 MPa.
- the PTFE is a monofilament ribbon, and preferably the width of the ribbon is in the range 0.5 - 4mm, more preferably 1 - 3mm, most preferably 1.2 - 2.4mm.
- the thickness is preferably in the range 20 - 120 ⁇ m, more preferably 20 - lOO ⁇ m and most preferably 40 - lOO ⁇ m.
- the ribbon may be twisted.
- the floss has typically a density of about 0.9g/cm 3 with typical pore size of approximately lO ⁇ m.
- the melting point of the coating material should preferably be above normal blood temperature to avoid melting on finger contact, i.e. at least 38 ⁇ C, more preferably at least 40 °C, and preferably is in the range 42 to 62°C.
- the PTFE element or elements are coated with coating material which (excluding any additive material which may be included as described below) is at least 90% by weight of at least one compound selected from mono-, di- and tri- glycerides of fatty acids having 14 to 20 carbon atoms, C 14 -C 20 aliphatic alcohols and C 14 -C 20 aliphatic acids. More preferably, the coating material (excluding any additive material) is at least 90% by weight of one or more compounds selected from mono-, di- and tri-glycerides of stearic, oleic and palmitic acids, stearic acid, stearyl alcohol, and cetyl alcohol .
- the coating may consist substantially wholly of such materials (apart from any additive included) .
- Such coatings to be used in the invention share the following common features; they are not waxes (i.e. they do not have wax characteristics, such as wide melting point range, do not exhibit softening prior to melting when heated to melting and on the floss do not have a waxy feel) ; they have relatively low melting points; the melting temperature range is narrow, e.g. not more than 10 °C, particularly not more than 6°C, preferably not more than 4°C, more preferably not more than 2'C; they are insoluble in water, they are non-toxic and preferably of food quality.
- the narrow melting temperature range is advantageous in manufacture of the floss, because the coating when applied as a liquid just above its melting temperature can be quickly solidified, giving an even and uniform coating.
- coatings which may be used include, but are not limited to, stearic acid, palmitic acid, glyceryl monostearate, stearyl alcohol, cetyl alcohol and hydrogenated castor oil.
- the coating may be on one or both sides of the PTFE ribbon-shaped element.
- the amount of the coating is preferably in the range 0.2 to 10% by weight of the dental floss, more preferably 0.2 to 5%, e.g. 1 to 5%.
- the dental floss may include a water-soluble or water- insoluble additive material adapted to be released in the mouth in use of the floss to provide a medicinal, diagnostic, cosmetic or flavouring effect, said adjuvant material being located within the PTFE material of the PTFE element or elements and/or on the surface of said PTFE element or elements under the coating, or in the coating.
- a suitable method of incorporating such adjuvants in the PTFE is described in WO97/24078 (US patent 5800823) .
- melting point means the temperature of first appearance of liquid on heating.
- the melting temperature range is the temperature range from first appearance of liquid (solidus) to disappearance of all solid (liquidus) .
- Glyceryl monostearate is a known pharmaceutical excipient and is composed of a mixture of mono-, di-, and tri-glycerides of primarily stearic and palmitic acids. Some oleate radicals may be present . It contains not less than 90% of total fatty acid glycerides, of which at least 35% are the stearic acid monoglyceride .
- the glyceryl monostearate used in this example had a melting point of 58 °C and a melting temperature range of about 2'C (i.e. 58 - 60"C) .
- the glyceryl monostearate is heated to melting point and then held at about 60 °C whilst a lick roller is partially immersed in the molten mass.
- the lick roller is driven so as to pick up a thin film of the glyceryl monostearate which is then transferred onto essentially one side only of a tape-shaped PTFE filament of dental floss dimensions which is pulled over the exposed surface of the roller.
- the filament is wound onto bobbins for packaging in dispensers.
- the PTFE filament was one made in accordance with WO 96/10478.
- Glyceryl monostearate is thus applied in a suitable amount to provide the desired handling properties in use. Excessive coating may make the floss hard and brittle in use .
- the amount of glyceryl monostearate in the coated floss is approximately 0.2 - 10% w/w, preferably 0.5 - 5% w/w (weight of glyceryl monostearate/weight of floss) .
- the PTFE filament which is the same as used in Example 1, is treated to incorporate a flavouring by immersion batchwise in an alcohol solution of dental mint flavour.
- the immersion may be done in a continuous process with the coating, but in either case the alcohol is allowed to evaporate before coating.
- the flavour may also be incorporated into the filament without the use of alcohol.
- the level of flavouring is 1 - 50%, preferably 3 - 10%, in the filament.
- the PTFE fibre is then coated with glyceryl monostearate in the same manner as in Example 1.
- the filament is coated with glyceryl monostearate at 0.5 - 5% w/w.
- the glyceryl monostearate used has a narrow melting temperature range of about 2°C.
- the product exhibits only a small amount of odour in comparison to the quantity of flavour added but, on use in the mouth, the flavour is intensified. This indicates that the flavour is essentially present in the pores of the PTFE filament and is shielded by the coating on one side. As the coating is insoluble in water this suggests that the coating is being mechanically removed from the surface of the PTFE floss during use. It may be that the flavour is released by the external force applied to the floss during use, compression of the floss forcing the flavour to migrate to the surface. Two-sided coating may be employed to give better shielding of the flavour in the PTFE.
- active components may be incorporated, e.g. active components incorporated during manufacture of the PTFE element or incorporated in the coating.
- active components may include, but are not limited to, fluoride-containing compounds, plaque control agents, tartar control agents, teeth whitening and bleaching agents, antibacterial agents, antifungal agents, vitamins, minerals, cooling agents e.g. menthol, colourant agents or dyes to identify plaque deposits, pharmacologically active compounds such as antibiotics, antigens, anti-inflammatory agents, analgesic agents, and haemostatic agents.
- Example 1 is repeated with incorporation of sodium fluoride in the coating.
- Sodium fluoride is added to the coating material in the coating bath at a level of 9% w/w. Since the sodium fluoride is not dissolved in the coating and remains suspended as discrete particles, the melting point of the coating is unaffected.
- the amount of coating material in the coated floss is approximately 0.5 - 5% w/w.
- the coated PTFE has been shown to release about 30% of the sodium fluoride present in the coating into water at 37 * C, thus indicating useful release into the mouth in use of the floss.
- EXAMPLE 4 has been shown to release about 30% of the sodium fluoride present in the coating into water at 37 * C, thus indicating useful release into the mouth in use of the floss.
- the PTFE filament which is the same as that used in Example 1, is treated in the same manner with a coating comprising a mixture of glyceryl monostearate, stearyl alcohol and sodium fluoride in the ratios 10:1:1 by weight .
- the sodium fluoride is not dissolved in the coating.
- the melting point of this mixture is about 58 'C.
- the PTFE is coated with the mixture at 0.5 - 5% w/w.
- the coated PTFE has been shown to release approximately 50% of the sodium fluoride in the coating into water at 37 ° C .
- EXAMPLE 5 The PTFE filament, which is the same as that used in Example 1, is given a coating as described in Example
- CPC cetylpyridinium chloride
- the PTFE is coated with the mixture at 0.5 - 5% w/w.
- the coated PTFE has been shown to release approximately 50% of the sodium fluoride into water at 37°C.
- EXAMPLE 6 The PTFE filament, which is the same as that used in Example 1, is given a coating as described in Example
- Triclosan, CPC and sodium fluoride are not dissolved in the coating, and the melting point of the coating mixture is about 58 'C.
- the PTFE is coated at 0.5 - 5% w/w. The coated PTFE has been shown to release approximately 50% of the sodium fluoride into water at 37'C.
- Triclosan is a water-insoluble additive but does show antibacterial action when released from the coating when the coating is mechanically removed from the filament .
- EXAMPLE 7 The PTFE filament, which is the same as that used in Example 1, is treated in the same manner to apply a coating of stearyl alcohol containing sodium fluoride at a level of 9% w/w.
- Stearyl alcohol has a melting point of about 58 "C and a melting point range of approximately 58 - 60 * C.
- the PTFE is coated with the mixture at a level of 0.5 - 5% w/w.
- Sodium fluoride is released into water at a level of approximately 50% at 37°C.
- EXAMPLE 8 EXAMPLE 8
- the PTFE filament is coated in the same manner with stearyl alcohol containing 5% sodium bicarbonate and 5% sodium fluoride.
- the PTFE is coated with the mixture at 0.5 - 5% w/w.
- the coated PTFE has been shown to release approximately 70-80% of the sodium fluoride into water at 37 'C. The same effect was obtained when silica was used instead of sodium bicarbonate.
- the PTFE filament is coated with the mixture described in Example 8 but containing 5% CPC.
- the PTFE is coated with the mixture at 0.5 - 5% w/w.
- the coated PTFE has been shown to release approximately 70-80% of the sodium fluoride into water at 37"C. CPC is released into water similarly.
- the PTFE filament is coated with the mixture described in Example 8 but containing 5% triclosan.
- the coated PTFE has been shown to release approximately 70- 80% of the sodium fluoride into water at 37 °C.
- the PTFE filament is treated to incorporate dental mint flavour by the processes described in Example 2.
- the PTFE filament is then coated with stearyl alcohol which has a melting point of about 58 °C and a melting point range of 58 - 60 ° C approximately.
- the filament is coated with stearyl alcohol at 0.5 - 5% w/w and displays properties similar to those of the product of Example 2.
- the dental floss consisting of or comprising the PTFE tape described above, can be packaged in a conventional manner, for example in a container such as a plastics material box, with an outlet aperture through which the tape can be pulled.
- the tape can be packed loosely in the box, or wound on a spool in the box.
- the box may have a cutting means for assisting the breaking of the floss, and this may be a notch.
- the PTFE tape can be used as a floss element in a flossing device, e.g. of the type where the floss element extends between two holding arms of a frame.
- a flossing device e.g. of the type where the floss element extends between two holding arms of a frame.
- the preferred dimensions of the bobbins containing the coated PTFE tape used as dental floss are: product contents 45m, diameter up to 26mm and depth up to 10mm.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15708/99A AU1570899A (en) | 1997-12-19 | 1998-12-15 | Coating of ptfe dental floss |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9726909.6 | 1997-12-19 | ||
GBGB9726909.6A GB9726909D0 (en) | 1997-12-19 | 1997-12-19 | Coating of PTFE dental floss |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999032046A1 true WO1999032046A1 (fr) | 1999-07-01 |
Family
ID=10823935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1998/003762 WO1999032046A1 (fr) | 1997-12-19 | 1998-12-15 | Revetement pour fil dentaire en ptfe |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1570899A (fr) |
GB (1) | GB9726909D0 (fr) |
WO (1) | WO1999032046A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044420A3 (fr) * | 1999-12-17 | 2002-07-04 | Archer Daniels Midland Co | Cires a base d'huiles glycerides |
WO2002053059A3 (fr) * | 2000-12-29 | 2003-05-15 | Kimberly Clark Co | Fil de soie dentaire et ruban dentaire enduits d'hemostatique |
WO2011097623A1 (fr) * | 2010-02-08 | 2011-08-11 | The Procter & Gamble Company | Fil dentaire revêtu à variabilité réduite |
WO2016084862A1 (fr) * | 2014-11-28 | 2016-06-02 | 旭硝子株式会社 | Compositions de caoutchouc fluoré et article en caoutchouc fluoré réticulé |
WO2019213298A1 (fr) * | 2018-05-01 | 2019-11-07 | Texas Tech University System | Fil dentaire à revêtement médicinal adaptable pour le traitement d'une maladie des gencives |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953566A (en) | 1970-05-21 | 1976-04-27 | W. L. Gore & Associates, Inc. | Process for producing porous products |
US3962153A (en) | 1970-05-21 | 1976-06-08 | W. L. Gore & Associates, Inc. | Very highly stretched polytetrafluoroethylene and process therefor |
EP0335466A2 (fr) | 1988-03-29 | 1989-10-04 | Colgate-Palmolive Company | Soie dentaire |
EP0423541A2 (fr) * | 1989-10-16 | 1991-04-24 | Colgate-Palmolive Company | Articles thérapeutiques à base de polytétrafluoroéthylène |
WO1992010978A1 (fr) | 1990-12-20 | 1992-07-09 | Westone Products Limited | Fil dentaire et son procede de fabrication |
GB2258402A (en) * | 1991-07-11 | 1993-02-10 | Colgate Palmolive Co | Coated ptfe dental floss |
WO1996010478A1 (fr) | 1994-10-03 | 1996-04-11 | Westone Products Limited | Procede et machine permettant d'obtenir du ptfe de forme allongee, et ptfe allonge utilise notamment comme soie dentaire |
WO1997024078A1 (fr) | 1995-12-27 | 1997-07-10 | Caredent Limited | Elements allonges en ptfe et articles obtenus a partir de ces elements |
US5665333A (en) * | 1995-01-17 | 1997-09-09 | Homola; Andrew M. | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
-
1997
- 1997-12-19 GB GBGB9726909.6A patent/GB9726909D0/en not_active Ceased
-
1998
- 1998-12-15 AU AU15708/99A patent/AU1570899A/en not_active Abandoned
- 1998-12-15 WO PCT/GB1998/003762 patent/WO1999032046A1/fr active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953566A (en) | 1970-05-21 | 1976-04-27 | W. L. Gore & Associates, Inc. | Process for producing porous products |
US3962153A (en) | 1970-05-21 | 1976-06-08 | W. L. Gore & Associates, Inc. | Very highly stretched polytetrafluoroethylene and process therefor |
EP0335466A2 (fr) | 1988-03-29 | 1989-10-04 | Colgate-Palmolive Company | Soie dentaire |
EP0423541A2 (fr) * | 1989-10-16 | 1991-04-24 | Colgate-Palmolive Company | Articles thérapeutiques à base de polytétrafluoroéthylène |
WO1992010978A1 (fr) | 1990-12-20 | 1992-07-09 | Westone Products Limited | Fil dentaire et son procede de fabrication |
GB2258402A (en) * | 1991-07-11 | 1993-02-10 | Colgate Palmolive Co | Coated ptfe dental floss |
WO1996010478A1 (fr) | 1994-10-03 | 1996-04-11 | Westone Products Limited | Procede et machine permettant d'obtenir du ptfe de forme allongee, et ptfe allonge utilise notamment comme soie dentaire |
US5657779A (en) | 1994-10-03 | 1997-08-19 | Westone Products Limited | Method and apparatus for forming elongate PTFE material and PTFE material particularly dental floss |
US5806539A (en) | 1994-10-03 | 1998-09-15 | Westone Products Limited | Method and apparatus for forming elongate PTFE material and PTFE material particularly dental floss |
US5665333A (en) * | 1995-01-17 | 1997-09-09 | Homola; Andrew M. | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
WO1997024078A1 (fr) | 1995-12-27 | 1997-07-10 | Caredent Limited | Elements allonges en ptfe et articles obtenus a partir de ces elements |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044420A3 (fr) * | 1999-12-17 | 2002-07-04 | Archer Daniels Midland Co | Cires a base d'huiles glycerides |
WO2002053059A3 (fr) * | 2000-12-29 | 2003-05-15 | Kimberly Clark Co | Fil de soie dentaire et ruban dentaire enduits d'hemostatique |
AU2002231216B2 (en) * | 2000-12-29 | 2006-03-02 | Kimberly-Clark Worldwide, Inc. | Hemostat coated dental floss and hemostat coated dental tape |
WO2011097623A1 (fr) * | 2010-02-08 | 2011-08-11 | The Procter & Gamble Company | Fil dentaire revêtu à variabilité réduite |
AU2011213605B2 (en) * | 2010-02-08 | 2014-04-24 | The Procter & Gamble Company | Reduced variability coated floss |
WO2016084862A1 (fr) * | 2014-11-28 | 2016-06-02 | 旭硝子株式会社 | Compositions de caoutchouc fluoré et article en caoutchouc fluoré réticulé |
WO2019213298A1 (fr) * | 2018-05-01 | 2019-11-07 | Texas Tech University System | Fil dentaire à revêtement médicinal adaptable pour le traitement d'une maladie des gencives |
US11623076B2 (en) | 2018-05-01 | 2023-04-11 | Texas Tech University System | Tailorable medicinally coated floss for the treatment of gum disease |
Also Published As
Publication number | Publication date |
---|---|
GB9726909D0 (en) | 1998-02-18 |
AU1570899A (en) | 1999-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0335466B1 (fr) | Soie dentaire | |
US5098711A (en) | Method of treating the oral cavity with dental floss containing chemotherapeutic agents | |
US5165913A (en) | Controlled release interproximal delivery system | |
US4911927A (en) | Method and apparatus for adding chemotherapeutic agents to dental floss | |
AU664182B2 (en) | Dental floss | |
CA1045552A (fr) | Sole et ruban dentaire aromatises | |
EP0959872B1 (fr) | Procedes, compositions et systemes d'administration dentaire servant a proteger la surface des dents | |
CA2259630C (fr) | Fil dentaire en polytetrafluoroethylene renfermant un ingredient | |
US7025986B2 (en) | Micromesh interproximal devices | |
US5680876A (en) | Floss brush manufacture and product | |
JPS6025969B2 (ja) | 香味つき歯科用品 | |
WO1999032046A1 (fr) | Revetement pour fil dentaire en ptfe | |
JP3499291B2 (ja) | 化学療法薬の付与されたデンタルフロス | |
EP1032324B1 (fr) | Fil dentaire | |
KR101986053B1 (ko) | 황칠 추출물을 이용한 치실 및 그 제조방법 | |
EP0506659B1 (fr) | Fil dentaire avec agents chimiotherapiques | |
JPH11155887A (ja) | デンタルフロス | |
WO2016093815A1 (fr) | Composition de revêtement de fil dentaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |